Tissue factor mediates microvesicles shedding from MDA-MB-231 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 502, Issue 1, 2018, Pages 137-144

  da R Rondon, Araci M ^a,c   de Almeida, Vitor H ^a   Gomes, Tainá ^a   Verçoza, Brunno R F ^a,b   Carvalho, Renato S ^a   König, Sandra ^a   Rodrigues, Juliany C F ^a,b   Mermelstein, Claudia dos S ^a   Versteeg, Henri H ^c   Monteiro, Robson Q ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Instituto Nacional de Ciência E Tecnologia de Biologia Estrutural E Bioimagem   (Brazil)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Breast cancer; Extracellular vesicles; Microvesicles (MVs); Tissue factor (TF)

Indexed keywords

ACTIN; FASUDIL; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; THROMBOPLASTIN;

ARTICLE; BREAST CANCER; CELLULAR SECRETION; CONTROLLED STUDY; CRISPR CAS SYSTEM; ENZYME ACTIVITY; EXOSOME; GENE KNOCKOUT; HUMAN; HUMAN CELL; MDA-MB-231 CELL LINE; MEMBRANE MICROPARTICLE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

EID: 85047299537     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2018.05.136     Document Type: Article

References (31)

1. Muralidharan-Chari, V., Clancy, J.W., Sedgwick, A., D'Souza-Schorey, C., Microvesicles: mediators of extracellular communication during cancer progression. J. Cell Sci. 123 (2010), 1603–1611, 10.1242/jcs.064386.
2. van der Pol, E., Böing, A.N., Gool, E.L., Nieuwland, R., Recent developments in the nomenclature, presence, isolation, detection and clinical impact of extracellular vesicles. J. Thromb. Haemostasis 14 (2016), 48–56, 10.1111/jth.13190.
3. Martins, V.R., Dias, M.S., Hainaut, P., Tumor-cell-derived microvesicles as carriers of molecular information in cancer. Curr. Opin. Oncol. 25 (2013), 66–75, 10.1097/CCO.0b013e32835b7c81.
4. Lima, L.G., Monteiro, R.Q., Activation of blood coagulation in cancer: implications for tumor progression. Biosci. Rep. 33 (2013), 701–710, 10.1042/BSR20130057.
5. Turturici, G., Tinnirello, R., Sconzo, G., Geraci, F., Extracellular membrane vesicles as a mechanism of cell-to-cell communication: advantages and disadvantages. Am. J. Physiol. Cell Physiol. 306 (2014), C621–C633, 10.1152/ajpcell.00228.2013.
6. Li, B., Antonyak, M.A., Zhang, J., Cerione, R.A., RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells. Oncogene 31 (2012), 4740–4749, 10.1038/onc.2011.636.
7. Antonyak, M.A., Wilson, K.F., Cerione, R.A., R(h)oads to microvesicles. Small GTPases 3 (2012), 219–224, 10.4161/sgtp.20755.
8. Versteeg, H.H., Heemskerk, J.W.M., Levi, M., Reitsma, P.H., New fundamentals in hemostasis. Physiol. Rev. 93 (2013), 327–358, 10.1152/physrev.00016.2011.
9. Rak, J., Milsom, C., Magnus, N., Yu, J., Tissue factor in tumour progression. Best Pract. Res. Clin. Haematol. 22 (2009), 71–83, 10.1016/j.beha.2008.12.008.
10. Mceachron, T., Mackman, N., Tumors, ticks and tissue factor. J. Thromb. Haemostasis 7 (2009), 1852–1854, 10.1111/j.1538-7836.2009.03592.x.
11. van den Berg, Y.W., Osanto, S., Reitsma, P.H., Versteeg, H.H., The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood 119 (2012), 924–932, 10.1182/blood-2011-06-317685.
12. Lima, L.G., Oliveira, A.S., Campos, L.C., Bonamino, M., Chammas, R., Werneck, C.C., Vicente, C.P., Barcinski, M.A., Petersen, L.C., Monteiro, R.Q., Malignant transformation in melanocytes is associated with increased production of procoagulant microvesicles. Thromb. Haemostasis 106 (2011), 712–723, 10.1160/TH11-03-0143.
13. Gomes, F.G., Sandim, V., Almeida, V.H., Rondon, A.M.R., Succar, B.B., Hottz, E.D., Leal, A.C., Verçoza, B.R.F., Rodrigues, J.C.F., Bozza, P.T., Zingali, R.B., Monteiro, R.Q., Breast-cancer extracellular vesicles induce platelet activation and aggregation by tissue factor-independent and -dependent mechanisms. Thromb. Res., 2017, 10.1016/j.thromres.2017.09.019.
14. Morel, O., Toti, F., Hugel, B., Bakouboula, B., Camoin-Jau, L., Dignat-George, F., Freyssinet, J.M., Procoagulant microparticles: disrupting the vascular homeostasis equation?. Arterioscler. Thromb. Vasc. Biol. 26 (2006), 2594–2604, 10.1161/01.ATV.0000246775.14471.26.
15. Lima, L.G., Leal, A.C., Vargas, G., Porto-Carreiro, I., Monteiro, R.Q., Intercellular transfer of tissue factor via the uptake of tumor-derived microvesicles. Thromb. Res., 2013, 10.1016/j.thromres.2013.07.026.
16. de Oliveira, A.S., de Almeida, V.H., Gomes, F.G., Rezaie, A.R., Monteiro, R.Q., TR47, a PAR1-based peptide, inhibits melanoma cell migration in vitro and metastasis in vivo. Biochem. Biophys. Res. Commun. 495 (2018), 1300–1304, 10.1016/j.bbrc.2017.11.174.
17. Ruf, W., Rehemtulla, A., Edgington, T.S., Antibody mapping of tissue factor implicates two different exon-encoded regions in function. Biochem. J. 278 (1991), 729–733.
18. Tanaka, Y., Sekiguchi, F., Hong, H., Kawabata, A., PAR2 triggers IL-8 release via MEK/ERK and PI3-kinase/Akt pathways in GI epithelial cells. Biochem. Biophys. Res. Commun. 377 (2008), 622–626, 10.1016/j.bbrc.2008.10.018.
19. Hjortoe, G.M., Petersen, L.C., Albrektsen, T., Sorensen, B.B., Norby, P.L., Mandal, S.K., Pendurthi, U.R., Rao, L.V.M., Tissue factor-factor VIIa-specific up-regulation of IL-8 expression in MDA-MB-231 cells is mediated by PAR-2 and results in increased cell migration. Blood 103 (2004), 3029–3037, 10.1182/blood-2003-10-3417.
20. Ott, I., Fischer, E.G., Miyagi, Y., Mueller, B.M., Ruf, W., A role for tissue factor in cell adhesion and migration mediated by interaction with actin-binding protein 280. J. Cell Biol. 140 (1998), 1241–1253, 10.1083/jcb.140.5.1241.
21. Silva, T.A., Smuczek, B., Valadão, I.C., Dzik, L.M., Iglesia, R.P., Cruz, M.C., Zelanis, A., de Siqueira, A.S., Serrano, S.M.T., Goldberg, G.S., Jaeger, R.G., Freitas, V.M., AHNAK enables mammary carcinoma cells to produce extracellular vesicles that increase neighboring fibroblast cell motility. Oncotarget, 2016, 10.18632/oncotarget.10307.
22. Baran, J., Baj-Krzyworzeka, M., Weglarczyk, K., Szatanek, R., Zembela, M., Barbasz, J., Czupryna, A., Szczepanik, A., Zembala, M., Circulating tumour-derived microvesicles in plasma of gastric cancer patients. Cancer Immunol. Immunother. 59 (2010), 841–850, 10.1007/s00262-009-0808-2.
23. Kim, H.K., Song, K.S., Park, Y.S., Kang, Y.H., Lee, Y.J., Lee, K.R., Kim, H.K., Ryu, K.W., Bae, J.M., Kim, S., Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor. Eur. J. Canc. 39 (2003), 184–191.
24. Menck, K., Bleckmann, A., Wachter, A., Hennies, B., Ries, L., Schulz, M., Balkenhol, M., Pukrop, T., Schatlo, B., Rost, U., Wenzel, D., Klemm, F., Binder, C., Characterisation of tumour-derived microvesicles in cancer patients' blood and correlation with clinical outcome. J. Extracell. Vesicles, 6, 2017, 10.1080/20013078.2017.1340745.
25. Collier, M.E.W., Maraveyas, A., Ettelaie, C., Filamin-A is required for the incorporation of tissue factor into cell-derived microvesicles. Thromb. Haemostasis 111 (2014), 647–655, 10.1160/TH13-09-0769.
26. Koizume, S., Ito, S., Yoshioka, Y., Kanayama, T., Nakamura, Y., Yoshihara, M., Yamada, R., Ochiya, T., Ruf, W., Miyagi, E., Hirahara, F., Miyagi, Y., High-level secretion of tissue factor-rich extracellular vesicles from ovarian cancer cells mediated by filamin-A and protease-activated receptors. Thromb. Haemostasis 115 (2016), 299–310, 10.1160/th15-03-0213.
27. Ciobanasu, C., Faivre, B., Le Clainche, C., Integrating actin dynamics, mechanotransduction and integrin activation: the multiple functions of actin binding proteins in focal adhesions. Eur. J. Cell Biol. 92 (2013), 339–348, 10.1016/j.ejcb.2013.10.009.
28. Peña, E., Arderiu, G., Badimon, L., Subcellular localization of tissue factor and human coronary artery smooth muscle cell migration. J. Thromb. Haemostasis 10 (2012), 2373–2382, 10.1111/j.1538-7836.2012.04910.x.
29. Ohta, Y., Suzuki, N., Nakamura, S., Hartwig, J.H., Stossel, T.P., The small GTPase RalA targets filamin to induce filopodia. Proc. Natl. Acad. Sci. U. S. A 96 (1999), 2122–2128, 10.1073/pnas.96.5.2122.
30. Koch, J.C., Tatenhorst, L., Roser, A.-E., Saal, K.-A., Tönges, L., Lingor, P., ROCK inhibition in models of neurodegeneration and its potential for clinical translation. Pharmacol. Ther., 2018, 10.1016/j.pharmthera.2018.03.008.
31. Guerra, F.S., De Oliveira, R.G., Fraga, C.A.M., Mermelstein, C.D.S., Fernandes, P.D., ROCK inhibition with Fasudil induces beta-catenin nuclear translocation and inhibits cell migration of MDA-MB 231 human breast cancer cells. Sci. Rep. 7 (2017), 1–8, 10.1038/s41598-017-14216-z.